Next, we asked whether concurrent loss of APC and APC2 was breast cancer subtype specific and detected an enrichment of dual loss for triple-negative breast cancers (Fisher’s exact test two tailed P<0.0001 in both data sets) (Figure 6a). This evidence concerns the gene APC2 and breast carcinoma.